Suppr超能文献

神经外室管膜瘤:贝伐珠单抗治疗后出现远处骨骼、肺、肝和淋巴结转移。

Extraneural ependymoma: distant bone, lung, liver, and lymph node metastases following bevacizumab.

机构信息

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York City, NY 10065, USA.

出版信息

Pediatr Blood Cancer. 2013 Jan;60(1):143-5. doi: 10.1002/pbc.24268. Epub 2012 Sep 13.

Abstract

Extraneural metastases of ependymoma are rare, and have been reported in the lungs, lymph nodes, pleura, mediastinum, liver, diaphragmatic muscle, and bone. We report a case of anaplastic ependymoma with distant metastases to the vertebral bones, lungs, liver, and lymph nodes following treatment with bevacizumab. Recent research has hypothesized that angiogenic tumors may develop means of resistance to antiangiogenic therapies, and some evidence suggests potential for antiangiogenic therapies to promote additional means for cancer spread. Nevertheless, antiangiogenic therapies continue to demonstrate potential as potent therapies for the treatment of many cancers, and should continue to be researched for future uses.

摘要

神经外转移的室管膜瘤很少见,已有文献报道可转移至肺、淋巴结、胸膜、纵隔、肝、膈肌和骨。我们报告了一例接受贝伐单抗治疗后发生远处转移至椎骨、肺、肝和淋巴结的间变性室管膜瘤。最近的研究假设血管生成肿瘤可能会产生对抗血管生成治疗的耐药机制,一些证据表明抗血管生成治疗可能会促进癌症扩散的其他途径。然而,抗血管生成治疗仍然具有作为许多癌症治疗的有效治疗方法的潜力,并且应该继续研究其未来用途。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验